Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ACCOMPLISH: Amlodipine/Benazepril vs Benazepril/HCTZ in High Risk Hypertension
NCT00170950Phase 3Terminated
- Sponsor
- Novartis
- Start
- Oct 2003
- Primary completion
- Jan 2008
- Modality
- Small Molecules
- Countries
- 5
01
Overview
Phase 3, randomised, double-blind trial in hypertension (HTN) comparing Benazepril/amlodipine with Benazepril/hydrochlorothiazide (2 arms). Primary endpoint: Time-to-event Analysis of Percentage of Patients With a Composite Cardiovascular (CV) Morbidity or Mortality Event at 33.4 months. Started Oct 2003; status: terminated.
02
Drugs
amlodipinebenazepril
03
Conditions
hypertension (HTN)
Beyond the preview
Go deeper on NCT00170950.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00170950.